Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/clc.23406 http://scihub22266oqcxt.onion/10.1002/clc.23406 32533585!7323229!32533585     free     free     free       Clin+Cardiol 2020 ; 43 (11): 1216-1222 Nephropedia Template TP {{tp|p=32533585|t=2020. COVID-19 and the heart: An update for clinicians |pdf=|usr=}}{{32533585}} gab.com Text COVID-19 and the heart: An update for clinicians JO: Clin Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=32533585 #FOAvip SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management. Twit Text FOAVip COVID-19 and the heart: An update for clinicians ????Clin Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=32533585 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32533585 #FOAvip English Wikipedia <ref>{{Cite pmid|32533585}}</ref> COVID-19 and the heart: An update for clinicians #MMPMID32533585 Goha A; Mezue K; Edwards P; Nunura F; Baugh D; Madu E Clin Cardiol 2020[Nov]; 43 (11): 1216-1222 PMID32533585show ga SARS-CoV-2, the cause of the COVID-19 pandemic has significantly impacted cardiovascular healthcare. Patients with pre-existing cardiovascular disease are at higher risk of morbidity and mortality. The virus may affect the heart directly and indirectly with clinical syndromes of acute myocardial injury, myocarditis, acute coronary syndromes, heart failure, arrhythmias, and venous thromboembolism. Some therapeutics under investigation for COVID-19 may also have adverse cardiac effects. The involvement of the RAAS system in viral entry makes it pertinent to consider the effects of medications that modulate the system. Comprehensive knowledge of peculiar cardiovascular manifestations of COVID-19 and the role of RAAS in the prognosis of COVID-19 disease is needed for optimal patient management. |*Betacoronavirus[MESH] |COVID-19[MESH] |Cardiovascular Diseases/therapy/*virology[MESH] |Coronavirus Infections/*complications/therapy[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/therapy[MESH] |Renin-Angiotensin System/*physiology[MESH] |Risk Factors[MESH]COVID-19 and the heart: An update for clinicians (epmc).pdf DeepDyve Pubget Overpricing